8113.T JPX
Unicharm Corporation
1W: -4.1%
1M: -8.0%
3M: -2.8%
YTD: -4.0%
1Y: -8.8%
3Y: -45.4%
5Y: -35.5%
¥917.50 ($5.82)
-19.40 (-2.07%)
Weekly Expected Move ±2.4%
¥873
¥895
¥918
¥940
¥962
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
#2
of 37
Household & Personal Products
Technical Signal Map
3 Bullish
1 Neutral
9 Bearish
8113.T
$1.6T
Unicharm Corporation
BEARISH
-84
4967.T
$520B
Kobayashi Pharmaceutical Co., Ltd.
BULLISH
+100
7806.T
$356B
MTG Co., Ltd.
BULLISH
+59
4919.T
$105B
Milbon Co., Ltd.
BULLISH
+44
7956.T
$244B
Pigeon Corporation
NEUTRAL
+1
4527.T
$637B
Rohto Pharmaceutical Co.,Ltd.
BEARISH
-59
4927.T
$302B
Pola Orbis Holdings Inc.
BEARISH
-68
4912.T
$481B
Lion Corporation
BEARISH
-75
4928.T
$153B
Noevir Holdings Co., Ltd.
BEARISH
-78
4911.T
$1.4T
Shiseido Company, Limited
BEARISH
-84
4922.T
$312B
KOSÃ Corporation
BEARISH
-84
4452.T
$3.1T
Kao Corporation
BEARISH
-100
4985.T
$101B
Earth Corporation
BEARISH
-100
Peer Comparison
| Symbol | Mkt Cap | P/E | ROE % | ROIC % | Net Mgn % | Rev Grw % | Piotroski | Signal | 1Y Ret % |
|---|---|---|---|---|---|---|---|---|---|
| 8113.T Unicharm Corporation | $1.6T | 24.7 | 8.2 | 13.7 | 8.4 | 0.3 | 7 | BEARISH | -8.8 |
| 4967.T Kobayashi Pharmaceutical Co., Ltd. | $520B | 325.0 | 2.0 | 3.8 | 0.3 | -15.6 | 7 | BULLISH | 30.8 |
| 7806.T MTG Co., Ltd. | $356B | 28.5 | 21.0 | 19.8 | 12.1 | 38.2 | 5 | BULLISH | 78.0 |
| 4919.T Milbon Co., Ltd. | $105B | 19.0 | 5.7 | 8.9 | 9.7 | 0.7 | 6 | BULLISH | 28.1 |
| 7956.T Pigeon Corporation | $244B | 26.4 | 11.8 | 18.3 | 9.3 | 8.2 | 7 | NEUTRAL | 14.4 |
| 4527.T Rohto Pharmaceutical Co.,Ltd. | $637B | 19.0 | 12.2 | 10.9 | 6.6 | 11.4 | 7 | BEARISH | 13.1 |
| 4927.T Pola Orbis Holdings Inc. | $302B | 25.9 | 3.9 | 9.7 | 7.9 | -0.9 | 7 | BEARISH | -0.8 |
| 4912.T Lion Corporation | $481B | 16.6 | 9.2 | 8.2 | 5.6 | 6.2 | 6 | BEARISH | 7.7 |
| 4928.T Noevir Holdings Co., Ltd. | $153B | 19.0 | 15.9 | 26.4 | 8.9 | 1.0 | 9 | BEARISH | -1.0 |
| 4911.T Shiseido Company, Limited | $1.4T | -63.5 | -3.3 | 3.5 | 8.0 | 5.0 | 7 | BEARISH | 26.3 |
| 4922.T KOSÃ Corporation | $312B | 22.4 | 4.6 | 5.3 | 6.1 | 0.8 | 8 | BEARISH | -8.6 |
| 4452.T Kao Corporation | $3.1T | 23.1 | 12.5 | 12.1 | 7.6 | 6.2 | 7 | BEARISH | -49.0 |
| 4985.T Earth Corporation | $101B | 21.5 | 24.2 | 26.0 | 7.1 | 25.1 | 6 | BEARISH | -17.1 |
| 8113.T Unicharm Corporation | $1.6T | 24.7 | 8.2 | 13.7 | 8.4 | 0.3 | 7 | BEARISH | -8.8 |
| 4967.T Kobayashi Pharmaceutical Co., Ltd. | $520B | 325.0 | 2.0 | 3.8 | 0.3 | -15.6 | 7 | BULLISH | 30.8 |
| 7806.T MTG Co., Ltd. | $356B | 28.5 | 21.0 | 19.8 | 12.1 | 38.2 | 5 | BULLISH | 78.0 |
| 4919.T Milbon Co., Ltd. | $105B | 19.0 | 5.7 | 8.9 | 9.7 | 0.7 | 6 | BULLISH | 28.1 |
| 7956.T Pigeon Corporation | $244B | 26.4 | 11.8 | 18.3 | 9.3 | 8.2 | 7 | NEUTRAL | 14.4 |
| 4527.T Rohto Pharmaceutical Co.,Ltd. | $637B | 19.0 | 12.2 | 10.9 | 6.6 | 11.4 | 7 | BEARISH | 13.1 |
| 4927.T Pola Orbis Holdings Inc. | $302B | 25.9 | 3.9 | 9.7 | 7.9 | -0.9 | 7 | BEARISH | -0.8 |
| 4912.T Lion Corporation | $481B | 16.6 | 9.2 | 8.2 | 5.6 | 6.2 | 6 | BEARISH | 7.7 |
| 4928.T Noevir Holdings Co., Ltd. | $153B | 19.0 | 15.9 | 26.4 | 8.9 | 1.0 | 9 | BEARISH | -1.0 |
| 4911.T Shiseido Company, Limited | $1.4T | -63.5 | -3.3 | 3.5 | 8.0 | 5.0 | 7 | BEARISH | 26.3 |
| 4922.T KOSÃ Corporation | $312B | 22.4 | 4.6 | 5.3 | 6.1 | 0.8 | 8 | BEARISH | -8.6 |
| 4452.T Kao Corporation | $3.1T | 23.1 | 12.5 | 12.1 | 7.6 | 6.2 | 7 | BEARISH | -49.0 |
| 4985.T Earth Corporation | $101B | 21.5 | 24.2 | 26.0 | 7.1 | 25.1 | 6 | BEARISH | -17.1 |
Profile Radar
Valuation vs Profitability
Performance Comparison
Industry Market Share
8113.T vs Benchmarks
ROIC
Gross Margin
Op Margin
Net Margin
Revenue Growth
P/E Ratio
ROE
Piotroski F